Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy.
Hematol Oncol. 2023 Aug;41(3):301-309. doi: 10.1002/hon.3088. Epub 2022 Oct 25.
Hematol Oncol. 2023.
PMID: 36251458
Review.
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis.
Cao HY, Wan CL, Xue SL.
Cao HY, et al.
Ann Hematol. 2023 Jan;102(1):155-165. doi: 10.1007/s00277-022-05040-1. Epub 2022 Nov 17.
Ann Hematol. 2023.
PMID: 36394582
Item in Clipboard
[Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia].
Wu TM, Xue SL, Li Z, Yu JQ, Wang J, Wang BR, Wan CL, Shen XD, Qiu QC, Bao XB, Wu DP.
Wu TM, et al.
Zhonghua Xue Ye Xue Za Zhi. 2021 Aug 14;42(8):646-653. doi: 10.3760/cma.j.issn.0253-2727.2021.08.006.
Zhonghua Xue Ye Xue Za Zhi. 2021.
PMID: 34547870
Free PMC article.
Chinese.
Item in Clipboard
Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia.
Zhang T, Zhou H, Xu M, Qian C, Sun A, Wu D, Xue S.
Zhang T, et al.
Ann Hematol. 2023 Apr;102(4):973-975. doi: 10.1007/s00277-023-05110-y. Epub 2023 Feb 6.
Ann Hematol. 2023.
PMID: 36745193
No abstract available.
Item in Clipboard
Cite
Cite